Presentation Information
[EOP1-2]Minimally Invasive Surgical Options and Risk Factor Analysis for Esophageal Cancer after Neoadjuvant Immunotherapy Combined with Chemotherapy
Muhu Tang (The First Affiliated Hospital, Zhejiang University School of Medicine)
Password required to view
Comment
To browse or post comments, you must log in.Log in